SEATTLE, May 15 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI)
(Nasdaq and MTA: CTIC) management will present at the Rodman & Renshaw 5th
Annual Global Healthcare Conference on Monday, May 19th at 9:40 AM in the
Atlantique Salon, Meridional at the Le Meridien Beach Plaza Hotel in
Monaco.
The presentation will also be webcast live with slides, and available
for replay after the presentation. The webcast can be accessed at
http://www.celltherapeutics.com.
Rodman & Renshaw 5th Annual Global Healthcare Conference
CTI Presentation: Monday, May 19, 2008
9:40 AM CET/3:40 AM ET/12:40 AM PT
Atlantique Salon, Meridional -- Le Meridien Beach Plaza Hotel, Monaco.
Audio webcast with slides at http://www.celltherapeutics.com.
Media Contact: Investors Contact :
Cell Therapeutics, Inc. Cell Therapeutics, Inc.
Dan Eramian Leah Grant
T: 206.272.4343 T: 206.272.4345
F: 206.272.4434 F: 206.272.4434
Lindsey Jesch http://www.celltherapeutics.com/investors.htm
T: 206.272.4347
F: 206.272.4434
E: media@ctiseattle.com
E: invest@ctiseattle.com
http://www.celltherapeutics.com/media.htm
'/>"/>SOURCE Cell Therapeutics, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 Related biology technology :1.
Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway2.
Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination3.
ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering4.
Nile Therapeutics, Inc. Adds to Executive Management Team5.
Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer6.
Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)7.
Cell Therapeutics, Inc. (CTI) Announces 2007 Annual Shareholders Meeting Results8.
Northwest Biotherapeutics, Inc. Announces Appointment of Chief Financial Officer9.
Nile Therapeutics, Inc. to Present at Upcoming BIO Investor Forum10.
Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event11.
Cell Therapeutics, Inc. (CTI) BIO Presentation to Be Webcast